Employing a glutathione-s-transferase-tag and hyaluronidase to control cytokine retention and release from a hyaluronic acid hydrogel matrix
Authors:
- 6 August 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (5) , 631-639
Abstract
Thiolated hyaluronic acid can be combined with poly-(ethylene glycol)-diacrylate to generate a self-polymerizing hydrogel with potential applications as an injectable depot for targeted drug delivery. There is a specific need for formulations that can incorporate and control the delivery of protein-based biologics over time. In this investigation, the incorporation and release of recombinant human granulocyte macrophage-colony stimulating factor and interleukin-4 from a commercial hyaluronic acid-based hydrogel was initially examined. The release profile was rapid; essentially complete within the first 4–24 h. However, addition of a glutathione-s-transferase-tag to these cytokines reduced their initial bolus release and extended the retention to more than three days. Hypothesizing a direct interaction of the glutathione-s-transferase-tag with poly-(ethylene glycol)-diacrylate, we observed a concentration-dependent slowing of cytokine release and prolonged retention as poly-(ethylene glycol)-diacrylate concentration was increased. Hyaluronidase was then added to promote a controlled degradation and independently modulate release rate and duration. The effects were concentration-dependent, resulting in a flexible hydrogel platform in which loading and release can be independently adjusted to meet a range of delivery needs. When injected in vivo, a localized cytokine reservoir was created and exhibited the same features as observed in vitro. These findings identify a tunable platform for the targeted local delivery and controlled release of protein-based biologics.Keywords
Funding Information
- National Institutes of Health/National Institute of Allergy and Infectious Diseases (5P30-AI028697-S1 to AH)
- University of California Cancer Research Coordinating Committee (To Michael D. Roth)
This publication has 27 references indexed in Scilit:
- Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogelBiomaterials, 2012
- Modified Hyaluronan Hydrogels Support the Maintenance of Mouse Embryonic Stem Cells and Human Induced Pluripotent Stem CellsMacromolecular Bioscience, 2012
- Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicineJournal of Controlled Release, 2011
- Structural, mechanical and osmotic properties of injectable hyaluronan-based composite hydrogelsPolymer, 2010
- A star-PEG–heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseasesBiomaterials, 2009
- Effect of Gelatin on Heparin Regulation of Cytokine Release from Hyaluronan-Based HydrogelsDrug Delivery, 2008
- Synthesis and Characterization of Novel Thiol-Reactive Poly(ethylene glycol) Cross-Linkers for Extracellular-Matrix-Mimetic BiomaterialsBiomacromolecules, 2007
- Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGFBiomaterials, 2006
- Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factorBiomaterials, 2005
- Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and patternBiomaterials, 2005